Wednesday November 4, 2026
66° San Francisco, CA
Become a Contributor
Section

Accesswire

Join 60 Degrees Pharmaceuticals’ Live Investor Webinar: Advancing Tafenoquine for Babesiosis While Expanding ARAKODA(R) Commercialization
Press Release

Join 60 Degrees Pharmaceuticals’ Live Investor Webinar: Advancing Tafenoquine for Babesiosis While Expanding ARAKODA(R) Commercialization

Learn how 60 Degrees Pharmaceuticals is building on its FDA-approved antimalarial ARAKODA® while advancing tafenoquine

Read Full Story